GoodRx Holdings, Inc. Class A (GDRX)

Over the past six months, GoodRx Holdings, Inc. stock has experienced a decline, with the share price decreasing from $4.28 to $2.85. Key events impacting the stock include earnings reports and guidance, where the company revised its revenue growth expectations for 2024 but faced a reduced revenue growth outlook and uncertainty surrounding revenue guidance. Analyst ratings during this period have been mixed, with a consensus rating of "Hold".

January has historically shown the highest probability of a positive return for GoodRx Holdings Inc. stock, while November has the lowest. The broader Healthcare sector generally experiences seasonal strength from April 25 to December 4. However, only four years of data are available for GDRX's seasonal stock analysis, which may be insufficient for a reliable seasonal profile.

GoodRx Holdings, Inc. is a consumer-focused digital healthcare platform providing access to transparent and lower prices for prescription medications. It offers a price comparison platform, telehealth services, prescription fulfillment, and healthcare research and information. The company also provides healthcare products and solutions for pets and generates revenue from pharmacy benefit managers.

GoodRx Holdings, Inc. primarily operates in the United States.

GoodRx's brand reputation is associated with its mission of making healthcare affordable and accessible. The platform has millions of active users and a robust network of pharmacy partners. The company has expanded its offerings to include telehealth services and prescription fulfillment, further solidifying its position as a holistic health resource.

GoodRx Holdings, Inc. has 254 institutional owners and shareholders holding a total of 120,688,883 shares. Institutional shareholders own 34.57% of the company, while insiders own 15.86%. Major institutional owners include Francisco Partners Management, LP, Vanguard Group Inc, Ameriprise Financial Inc, Silver Lake Group, L.L.C., and Renaissance Technologies Llc. Significant individual and insider owners include Abdiel Capital Management LLC, Douglas Joseph Hirsch, and Trevor Bezdek. Insiders have sold a total of 71,818 GoodRx shares in the last 24 months.